vs
Brighthouse Financial, Inc.（BHF）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
Brighthouse Financial, Inc.的季度营收约是瑞思迈的1.2倍（$1.7B vs $1.4B），瑞思迈净利率更高（27.6% vs 8.1%，领先19.5%），Brighthouse Financial, Inc.同比增速更快（40.2% vs 11.0%），过去两年Brighthouse Financial, Inc.的营收复合增速更高（9.8% vs 7.8%）
Brighthouse Financial是总部位于美国北卡罗来纳州夏洛特的保险公司，核心业务为销售年金和人寿保险产品。截至2018年3月，该公司是美国规模领先的年金和人寿保险提供商之一，总资产达2190亿美元，有效保单及年金合约数量约260万份。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
BHF vs RMD — 直观对比
营收规模更大
BHF
是对方的1.2倍
$1.4B
营收增速更快
BHF
高出29.2%
11.0%
净利率更高
RMD
高出19.5%
8.1%
两年增速更快
BHF
近两年复合增速
7.8%
损益表 — Q4 FY2025 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.7B | $1.4B |
| 净利润 | $137.0M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | 8.9% | 34.6% |
| 净利率 | 8.1% | 27.6% |
| 营收同比 | 40.2% | 11.0% |
| 净利润同比 | -79.6% | 13.9% |
| 每股收益（稀释后） | $1.84 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BHFRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.7B | $1.4B | ||
| Q3 25 | $1.8B | $1.3B | ||
| Q2 25 | $871.0M | $1.3B | ||
| Q1 25 | $2.4B | $1.3B | ||
| Q4 24 | $1.2B | $1.3B | ||
| Q3 24 | $2.0B | $1.2B |
净利润BHFRMD
| Q2 26 | — | $392.6M | ||
| Q1 26 | — | $398.7M | ||
| Q4 25 | $137.0M | $392.6M | ||
| Q3 25 | $479.0M | $348.5M | ||
| Q2 25 | $85.0M | $379.7M | ||
| Q1 25 | $-268.0M | $365.0M | ||
| Q4 24 | $671.0M | $344.6M | ||
| Q3 24 | $176.0M | $311.4M |
毛利率BHFRMD
| Q2 26 | — | 61.8% | ||
| Q1 26 | — | 62.2% | ||
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% |
营业利润率BHFRMD
| Q2 26 | — | 34.6% | ||
| Q1 26 | — | 34.9% | ||
| Q4 25 | 8.9% | 34.6% | ||
| Q3 25 | 32.2% | 33.4% | ||
| Q2 25 | 10.7% | 33.7% | ||
| Q1 25 | -14.8% | 33.0% | ||
| Q4 24 | 69.2% | 32.5% | ||
| Q3 24 | 9.3% | 31.6% |
净利率BHFRMD
| Q2 26 | — | 27.6% | ||
| Q1 26 | — | 27.9% | ||
| Q4 25 | 8.1% | 27.6% | ||
| Q3 25 | 26.4% | 26.1% | ||
| Q2 25 | 9.8% | 28.2% | ||
| Q1 25 | -11.2% | 28.3% | ||
| Q4 24 | 55.7% | 26.9% | ||
| Q3 24 | 8.7% | 25.4% |
每股收益（稀释后）BHFRMD
| Q2 26 | — | $2.68 | ||
| Q1 26 | — | $2.74 | ||
| Q4 25 | $1.84 | $2.68 | ||
| Q3 25 | $7.89 | $2.37 | ||
| Q2 25 | $1.02 | $2.58 | ||
| Q1 25 | $-5.04 | $2.48 | ||
| Q4 24 | $10.27 | $2.34 | ||
| Q3 24 | $2.47 | $2.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.4B |
| 总债务越低越好 | $3.2B | $663.8M |
| 股东权益账面价值 | $6.8B | $6.3B |
| 总资产 | $241.8B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.47× | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资BHFRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | — | $1.7B | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $932.7M | ||
| Q4 24 | $1.9B | $521.9M | ||
| Q3 24 | $1.8B | $426.4M |
总债务BHFRMD
| Q2 26 | — | $663.8M | ||
| Q1 26 | — | $664.1M | ||
| Q4 25 | $3.2B | $403.9M | ||
| Q3 25 | $3.2B | $408.7M | ||
| Q2 25 | $3.2B | $658.4M | ||
| Q1 25 | $3.2B | $663.1M | ||
| Q4 24 | $3.2B | $662.9M | ||
| Q3 24 | $3.2B | $667.6M |
股东权益BHFRMD
| Q2 26 | — | $6.3B | ||
| Q1 26 | — | $6.5B | ||
| Q4 25 | $6.8B | $6.3B | ||
| Q3 25 | $6.4B | $6.1B | ||
| Q2 25 | $5.7B | $6.0B | ||
| Q1 25 | $5.2B | $5.5B | ||
| Q4 24 | $5.0B | $5.3B | ||
| Q3 24 | $5.5B | $5.2B |
总资产BHFRMD
| Q2 26 | — | $8.5B | ||
| Q1 26 | — | $8.8B | ||
| Q4 25 | $241.8B | $8.5B | ||
| Q3 25 | $244.7B | $8.3B | ||
| Q2 25 | $242.6B | $8.2B | ||
| Q1 25 | $234.7B | $7.6B | ||
| Q4 24 | $238.5B | $7.1B | ||
| Q3 24 | $245.2B | $7.2B |
负债/权益比BHFRMD
| Q2 26 | — | 0.11× | ||
| Q1 26 | — | 0.10× | ||
| Q4 25 | 0.47× | 0.06× | ||
| Q3 25 | 0.50× | 0.07× | ||
| Q2 25 | 0.56× | 0.11× | ||
| Q1 25 | 0.60× | 0.12× | ||
| Q4 24 | 0.64× | 0.13× | ||
| Q3 24 | 0.57× | 0.13× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.0M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | -0.02× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BHFRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $-3.0M | $339.7M | ||
| Q3 25 | $117.0M | $457.3M | ||
| Q2 25 | $-1.0M | $538.8M | ||
| Q1 25 | $146.0M | $578.7M | ||
| Q4 24 | $-118.0M | $308.6M | ||
| Q3 24 | $24.0M | $325.5M |
自由现金流BHFRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | $311.2M | ||
| Q3 25 | — | $414.4M | ||
| Q2 25 | — | $508.2M | ||
| Q1 25 | — | $557.9M | ||
| Q4 24 | — | $288.0M | ||
| Q3 24 | — | $307.7M |
自由现金流率BHFRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 21.9% | ||
| Q3 25 | — | 31.0% | ||
| Q2 25 | — | 37.7% | ||
| Q1 25 | — | 43.2% | ||
| Q4 24 | — | 22.5% | ||
| Q3 24 | — | 25.1% |
资本支出强度BHFRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 2.3% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 1.5% |
现金转化率BHFRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | -0.02× | 0.87× | ||
| Q3 25 | 0.24× | 1.31× | ||
| Q2 25 | -0.01× | 1.42× | ||
| Q1 25 | — | 1.59× | ||
| Q4 24 | -0.18× | 0.90× | ||
| Q3 24 | 0.14× | 1.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BHF
| Annuities | $926.0M | 55% |
| Runoff | $319.0M | 19% |
| Life | $298.0M | 18% |
| Other | $78.0M | 5% |
| Distribution Service | $66.0M | 4% |
| Accident And Health Insurance Segment | $2.0M | 0% |
RMD
暂无分部数据
